Probiota Global 2022 @Copenhagen, Denmark

Congres Probiota Global 2022@Copenhagen, Denmark Connecting the business and science of the microbiome.   Participation of Vincent THOMAS, head of Microbiota program.    

Safety and immunogenicity of a measles-vectored SARS-CoV-2 vaccine candidate, V591/TMV-083, in healthy adults: resuts of a randomized, placebo controlled Phase I study

Authors: Odile Launay, Cécile Artaud, Marie Lachâtre, Mohand Ait-Ahmed, Jelle Klein, Liem Binh Luong Nguyen, Christine Durier, Bastiaan Jansen, Yvonne Tomberger, Nathalie Jolly, Anna Grossmann, Houda Tabbal, Jérémy Brunet, Marion Gransagne, Zaineb Choucha, Damien Batalie, Ana Delgado, Matthias Müllner, Roland Tschismarov, Pieter-Jan Berghmans, Annette Martin, Katrin Ramsauer, Nicolas Escriou, Christiane Gerke DOI: 10.1016/j.ebiom.2021.103810